“VANCOUVER — A Vancouver biotech company working on a treatment for COVIDcampaign-pages/bispecifics/-19 has announced human testing for its antibody drug could start as soon as July. Vancouver-based AbCellera managed to isolate around 500 antibodies that are candidates for new therapeutics to treat or prevent infections.”
Read full coverage on CTV News.